Many people take semaglutide until: They reach a healthy, sustainable weight Hunger feels manageable without medication support Weight has remained stable for several months The goal isnt just losing weight, its keeping it off in a way that feels realistic
Now, however, she fears she wont be able to afford treatment moving forward
Current marketed formulations Semaglutide (Rybelsus, Ozempic, and Wegovy) Oral drug delivery offers significant advantages in terms of patient adherence, particularly in the chronic management of T2DM
If a reader clicks on such a link and makes a purchase, the publisher or its partners may receive a commission at no additional cost to the reader
Weight loss outcomes : Semaglutide at the doses used for weight management (Wegovy, 2.4 mg weekly) has produced average weight loss of 15-17% of body weight over 68 weeks in clinical trials (STEP program)